The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; Merck Serono; Roche; Servier
Consulting or Advisory Role - AstraZeneca; Basilea; Bayer; Bristol-Myers Squibb; Eisai; Elevar Therapeutics; Exelixis
Research Funding - Agios (Inst); AstraZeneca (Inst); BeiGene (Inst); Eisai (Inst); Exelixis (Inst); FibroGen (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); MSD (Inst); Nerviano Medical Sciences (Inst); Roche (Inst); Servier (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Phase 2/3 study of livmoniplimab in combination with budigalimab in patients with locally advanced or metastatic hepatocellular carcinoma.
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Abbvie; AstraZeneca; Autem Medical; Berry Genomics; BioNtech (I); Boehringer Ingelheim (I); Bristol-Myers Squibb/Medarex (I); Eisai; Exelixis; Ipsen; J-Pharma; Merck Serono (I); Merus NV (I); Neogene Therapeutics (I); Novartis (I); QED Therapeutics; Roche/Genentech; Servier; Tempus (I); Vector Health; Yiviva
Research Funding - Agenus (Inst); Arcus Ventures (Inst); AstraZeneca (Inst); BioNtech (Inst); Bristol-Myers Squibb (Inst); Elicio Therapeutics (Inst); Genentech/Roche (Inst); Helsinn Healthcare (Inst); Parker Institute for Cancer Immunotherapy (Inst); Pertzye (Inst); Puma Biotechnology (Inst); QED Therapeutics (Inst); Yiviva (Inst)
 
Mohamed Bouattour
Honoraria - Bayer Schering Pharma
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Roche; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Speakers' Bureau - Bayer; Roche; SIRTEX Medical
Research Funding - AstraZeneca (Inst); Bayer Schering Pharma (Inst); BMS GmbH & Co. KG (Inst); Incyte (Inst); Merck (Inst); MSD (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Ipsen; Roche
 
Ann-Lii Cheng
Honoraria - AstraZeneca; Bayer Yakuhin; Eisai; Genentech/Roche
Consulting or Advisory Role - AstraZeneca; Bayer Schering Pharma; BeiGene; Bristol-Myers Squibb; Eisai; Genentech/Roche; Ipsen; IQVIA; MSD; Omega Therapeutics, Inc.; Ono Pharmaceutical; Roche
 
Farshid Dayyani
Employment - Roche (I)
Consulting or Advisory Role - AstraZeneca; Eisai; Exelixis
Speakers' Bureau - Astellas Pharma; Exelixis; ipsen; SERVIER; Sirtex Medical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech (Inst); Ipsen (Inst); Merck (Inst); Taiho Pharmaceutical (Inst)
 
Danny Khalil
Consulting or Advisory Role - Abbvie; Akamis Bio; Celldex; PsiOxus Therapeutics
Research Funding - Merck (Inst)
Patents, Royalties, Other Intellectual Property - Intellectual property interests related to CD40, nanotechnology, and in situ vaccination.
 
Daneng Li
Consulting or Advisory Role - Abbvie; AstraZeneca; Delcath Systems; Eisai; Exelixis; Genentech; Merck; Sumitomo Pharma Oncology; Tersera; TransThera Biosciences; TriSalus Life Sciences
Speakers' Bureau - Eisai; Exelixis; Ipsen; SERVIER; Tersera
Research Funding - AstraZeneca (Inst)
 
Chih-Yi Liao
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boston Scientific; Exelixis; Genentech; Histosonics; Incyte; Ipsen; Lexicon; Lilly; QED Therapeutics; TransThera Biosciences
Speakers' Bureau - AstraZeneca; Eisai; Exelixis; Incyte
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Exelixis; Incyte; Ipsen
 
Carlos López López
Honoraria - Advanced Accelerator Applications; AstraZeneca; Bayer; Bristol Myers Squibb; Eisai; Ipsen; Merck; MSD Oncology; Novartis; Pfizer; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Eisai; Ipsen; Merck; Pfizer; Roche; Sanofi; SERVIER
Research Funding - Amgen; AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Merck Sharp & Dohme; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Ipsen; Merck; Pfizer; Roche; SERVIER
 
Lorenza Rimassa
No Relationships to Disclose
 
Jonathan Deutsch
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Junvie Pailden
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Maulik Patel
Employment - abbvie
Stock and Other Ownership Interests - Abbvie
 
Juki Ng
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Anne Henkel
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Cristiano Ferlini
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie